Xcout Intel
Casdin Capital competitors & alternatives
The 10 closest competitors and alternatives to Casdin Capital among asset management companies — ranked by similarity to what Casdin Capital actually does, not by market-cap band.
Subscribe to see Casdin Capital’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Casdin Capital
Casdin Capital is an investment firm focused on the life sciences and healthcare sectors, including biotechnology, medical technology, and related companies. It serves institutional and other sophisticated investors through investment strategies targeting growth and innovation in healthcare.
Casdin Capital at a glance
Casdin Capital is an asset management company headquartered in United States. Xcout tracks 10 named people at Casdin Capital, including Alexandria Fisk (Chief Operating Officer).
Casdin Capital leadership
- Alexandria FiskChief Operating Officer
- Lawrence CanzoneriChief Financial Officer
- Angelo CrupiChief Compliance Officer
- Kelly Axsom, MDChief Medical Officer
- Eli CasdinChief Investment Officer and Founder
- Bernie CooneySenior Managing Director
4 more named people on record for Casdin Capital, with roles, board committees and tenure — see the full roster →
Top 10 Casdin Capital competitors
Ranked by semantic similarity — how close each company is to Casdin Capital by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar asset management company
Forbion is a European venture capital firm focused on life sciences, including biotechnology and medical technology. It manages investment funds and provides capital to innovative healthcare companies, primarily serving entrepreneurs and investors in the European life sciences sector.
Biotech
Monograph Capital is a life-sciences investment firm that provides venture capital to companies developing innovative therapeutics and related healthcare technologies. It works with entrepreneurs and management teams building businesses in the biotechnology and healthcare sectors.
Similar asset management company
Schonfeld Strategic Advisors is a global investment firm that manages capital through multiple quantitative, fundamental, and discretionary trading strategies. It serves institutional and other qualified investors through hedge funds and related investment vehicles.
Similar asset management company
HBM Partners is a Swiss healthcare asset manager and investor that provides venture, growth, and buy-out financing to private and public companies in the biopharma, medtech, diagnostics, and healthcare sectors. The firm advises specialized equity investment funds and supports entrepreneurial companies by providing capital and strategic industry expertise.
Similar asset management company
KDventures is a listed investment company that invests in innovative pharmaceutical, biotech, and medical technology companies. Through active ownership and specialized life science expertise, the company supports its portfolio businesses in developing treatments for severe diseases.
Similar asset management company
RTW Venture Fund Limited primarily focuses on sourcing groundbreaking innovations poised for substantial growth within the biotechnology, pharmaceutical, and medical technology fields. The fund allocates capital to enterprises that are engineering advanced therapies and cutting-edge technologies, ultimately aiming to profoundly enhance patient quality of life.
Similar asset management company
Lightspeed Venture Partners is a venture capital firm that invests in early- and growth-stage technology companies across sectors such as artificial intelligence, cybersecurity, enterprise software, and healthcare. The firm provides financial backing and strategic support to entrepreneurs from the seed stage through later funding rounds.
Similar asset management company
Council Capital is a Nashville-based private equity firm focused on investing in and supporting growth-oriented healthcare companies. It partners with management teams and healthcare entrepreneurs, typically in lower-middle-market businesses across healthcare services and related sectors.
Similar asset management company
SCD Capital Corp. is a boutique investment firm that manages assets for various investors and serves as the general partner for a long/short equity fund. The company focuses on investing in industry leaders and fast-growing companies with an emphasis on capital preservation.
Similar asset management company
HBM Healthcare Investments AG strategically deploys capital through both direct investments and allocations to other funds, targeting middle-market and mature companies. Its investment mandate is broad, encompassing various stages from nascent startups, early-stage, mid-stage, and late-stage private ventures to emerging unlisted businesses, smaller public companies, management buyouts, growth capital opportunities, and private investments in public equities (PIPEs). Within its fund-of-funds segment, it specifically backs venture capital funds. The firm also provides financing for the spin-off of product lines or departments from larger corporations, supports the expansion or restructuring of established businesses, and participates in seed, venture, and expansion capital rounds, along with additional buyout transactions. HBM's primary focus is on private and public entities within the healthcare sector, with a strong emphasis on human medicine, pharmaceuticals (including biopharma), biotechnology, diagnostics, medical technology, and related industries. Initial investments are typically made in companies whose core products are either in clinical development or the stage immediately preceding it. The fund adopts a global investment approach, concentrating its efforts particularly on the Asia Pacific region, North America, and Europe. For publicly listed companies, HBM generally targets those that have transitioned from its private investment portfolio. The firm often increases its stake in portfolio companies by participating in subsequent financing rounds or after the company's initial public offering. HBM may acquire controlling interests in portfolio companies and frequently secures a seat on their Board of Directors. While equity investments are its predominant method, it also utilizes a range of other financial instruments, including convertible bonds, debt securities, structured products, and derivatives. HBM's primary exit strategies for its portfolio companies involve trade sales or initial public offerings.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Casdin Capital and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Casdin Capitaland every competitor above — in one live dashboard.
Subscribe to Xcout Intel →